Home > Journals > Minerva Urology and Nephrology > Past Issues > Articles online first > Minerva Urologica e Nefrologica 2020 Jun 22



To subscribe
Submit an article
Recommend to your librarian


Publication history
Cite this article as



Minerva Urologica e Nefrologica 2020 Jun 22

DOI: 10.23736/S0393-2249.20.03804-7


language: English

Bipolar plasmakinetic transurethral enucleation and resection versus bipolar plasmakinetic transurethral resection for surgically treating large (≥ 60 g) prostates: a propensity score-matched analysis with a 3-year follow-up

Wen DENG 1, 2, Luyao CHEN 1, Xiaoqiang LIU 1, 2, Hao JIANG 1, 2, Zhengtao ZHOU 1, 2, Yulei LI 1, 2, Gongxian WANG 1, 2, Bin FU 1, 2

1 Department of Urology, the First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province, China; 2 Jiangxi Institute of Urology, Nanchang City, Jiangxi Province, China


BACKGROUND: There are extremely limited published studies comparing bipolar plasmakinetic transurethral resection of prostate (BP-TURP) and bipolar plasmakinetic transurethral enucleation and resection of prostate (BP-TUERP) for enlarged prostates. Our purpose is to evaluate the safety and efficiency of BP-TUERP and BP-TURP for large (≥ 60 g) prostates with a 3-year follow-up.
METHODS: We retrospectively identified 229 patients according to inclusion criteria between 2014 and 2016. After applying propensity score matching method, preoperative results and three-year follow-up outcomes in International Prostate Symptom Score (IPSS), urinary peek flow rate (Qmax), postvoid residual urine (PVRU) volume and quality of life (QoL) score were compared.
RESULTS: Finally, within the well-balanced matched cohort, the BP-TUERP was significantly associated with longer mean operating time (OT) (p = 0.039), shorter mean catheter time (CT) (p = 0.001) and lower mean hemoglobin decrease (p = 0.002) with more prostatic tissue removed (p = 0.001) than the BP-TURP, but the median hospital stay lengths and the short- and long-term complication rates were similar between the two series. The patients in the BP-TUERP group had better long-term outcomes in IPSS, Qmax and PVRU volume than these in the BP-TURP group, but not in QoL score.
CONCLUSIONS: For patients with large (≥ 60 g) prostates, BP-TUERP and BP-TURP are safe options, but the former is a more effective choice in long-term follow-up outcomes. BP-TUERP is related to reduced CT and hemoglobin decrease with more removal of prostatic tissue at the expense of longer OT than BP-TURP.

KEY WORDS: Bipolar; Plasmakinetic; TUERP; TURP; BPH

top of page